The Protective Effect of Curcumin on Hepatic Function in Cancer Patients Receiving Taxane-Based Chemotherapy: A Randomized Controlled Clinical Trial

The Protective Effect of Curcumin on Hepatic Function in Cancer Patients Receiving Taxane-Based Chemotherapy: A Randomized Controlled Clinical Trial

Background: Cancer has become a significant health challenge in recent decades. The Taxane family is one of the popular chemotherapeutic agents which can cause hepatic injury. The present study was conducted with the aim of evaluating the hepatoprotective effect of Curcumin on cancer patients treate...

Full description

Bibliographic Details
Main Authors:	Hourieh Ansari, Ali Hajigholami, Danial Abbasi
Format:	Article
Language:	English
Published:	Shiraz University of Medical Sciences 2023-07-01
Series:	Middle East Journal of Cancer
Subjects:	taxane curcumin plant extracts neoplasms
Online Access:	https://mejc.sums.ac.ir/article_48972_747fbc068ad98dd4daf47ff058babe1e.pdf

Similar Items

Investigating the effect of zinc on the prevention of acute peripheral neuropathy in cancer patients treated with taxanes
by: Ali Haji Gholami, et al.
Published: (2022-01-01)

Cell death in cancer chemotherapy using taxanes
by: Ana P. Xu, et al.
Published: (2024-01-01)

Neoadjuvant chemotherapy outcome with taxane-based versus non-taxane protocols in gastric cancer
by: Shirin Kianersi, et al.
Published: (2023-01-01)

Diagnostic tools should be used for the diagnosis of chemotherapy induced peripheral neuropathy in breast cancer patients receiving taxanes
by: Frank vanHaren, et al.
Published: (2022-10-01)

Effects of adding taxane to anthracycline-based neoadjuvant chemotherapy in locally advanced breast cancer
by: Azra Rašić, et al.
Published: (2019-02-01)

Reliability and Validity of the Turkish Version of Chemotherapy-induced Peripheral Neuropathy Assessment Tool for Breast Cancer Patients Receiving Taxane Chemotherapy
by: Neriman Yükseltürk Simsek, et al.
Published: (2018-01-01)

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
by: Alex Molassiotis, et al.
Published: (2019-06-01)

New possibilities of chemotherapy for anthracyclineand/or taxane-resistant breast cancer
by: E V Artamonova, et al.
Published: (2013-06-01)

Taxane-induced acute interstitial pneumonitis in patients with breast cancer and outcome of taxane rechallenge
by: T M Anoop, et al.
Published: (2022-01-01)

Beau’s Lines Resulting from Taxane Chemotherapy
by: Kumpol Aiempanakit
Published: (2018-10-01)

A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy
by: Eun Hee Sohn, et al.
Published: (2021-04-01)

Outcomes of Triple-Negative Breast Cancer Patients in Response to Taxane and Nontaxane-Based Neoadjuvant Chemotherapies
by: Mohsin Khan, et al.
Published: (2022-06-01)

Sex Differences in Taxane Toxicities
by: Nicole N. Chmielewski, et al.
Published: (2022-07-01)

Symptoms Experience and Quality of Life in The Patients With Breast Cancer Receiving The Taxane Class of Drugs
by: Kamile Kırca, et al.
Published: (2018-07-01)

Microtubule Destabilizing Sulfonamides as an Alternative to Taxane-Based Chemotherapy
by: Myriam González, et al.
Published: (2021-02-01)

Taxane-based adjuvant chemotherapy in node positive, early stage Turkish breast cancer patients
by: Alacacioglu Ahmet, et al.
Published: (2009-12-01)

Parameter Optimization of Ultrasonic–Microwave Synergistic Extraction of Taxanes from <i>Taxus cuspidata</i> Needles
by: Zirui Zhao, et al.
Published: (2023-11-01)

Supplemental Preparations in Taxane-Induced Neuropathy Management
by: AmirHosein Sanei, et al.
Published: (2023-04-01)

The effects and mechanism of taxanes on chemotherapy-associated ovarian damage: A review of current evidence
by: Chuqing Wu, et al.
Published: (2022-11-01)

Successful Treatment with Taxane-Based Chemotherapy in Advanced Sebaceous Carcinoma: A Case Report and Literature Review
by: Shuji Ota, et al.
Published: (2019-01-01)

Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
by: Wanjing Chen, et al.
Published: (2021-02-01)

Taxanes in the Treatment of Advanced Gastric Cancer
by: Byung Woog Kang, et al.
Published: (2016-05-01)

Taxane-Induced Upper Gastrointestinal Bleeding
by: Yao Liu, et al.
Published: (2021-09-01)

Recognising Nail Changes Induced by Chemotherapy with Taxane-based Regimens and their Dermoscopic Confirmation: A Prospective Observational Study from Northern India
by: Rupinder Walia, et al.
Published: (2022-09-01)

Correlates of Taxane-Induced Neuropathy, an Electronic Health Record Based Observational Study
by: R. Dixon Dorand, et al.
Published: (2023-01-01)

Taxane-Induced Peripheral Neurotoxicity
by: Roser Velasco, et al.
Published: (2015-04-01)

The effect of pregabalin and duloxetine treatment on quality of life of breast cancer patients with taxane-induced sensory neuropathy: A randomized clinical trial
by: Razieh Avan, et al.
Published: (2018-01-01)

Mechanisms of Taxane Resistance
by: Sara M. Maloney, et al.
Published: (2020-11-01)

Breast Cancer: Clinical–Epidemiological Profile and Toxicities of Women Receiving Treatment with Taxanes in the Amazon Region
by: Marta Solange Camarinha Ramos Costa, et al.
Published: (2023-09-01)

Impact of taxane-based chemotherapeutics on male reproductive function
by: Charvi Kanodia, et al.
Published: (2023-04-01)

Taxane-induced morphea in a patient with CREST syndrome
by: Susan Michele Bouchard, et al.
Published: (2010-07-01)

Efficacy and safety of taxanes combined with chemotherapy drugs in advanced triple negative breast cancer: A meta-analysis of 26 randomized controlled trials
by: Qionglian Huang, et al.
Published: (2022-08-01)

The Role of TRIP6, ABCC3 and CPS1 Expression in Resistance of Ovarian Cancer to Taxanes
by: Karolina Seborova, et al.
Published: (2021-12-01)

Paclitaxel and other taxanes in hazelnut
by: Angela Hoffman, et al.
Published: (2009-01-01)

Long Noncoding RNAs in Taxane Resistance of Breast Cancer
by: Hailong Chen, et al.
Published: (2023-07-01)

Oral vinorelbine: its role in advanced breast cancer pre-treated with anthracycline and taxane chemotherapies
by: Fausto Petrelli, et al.
Published: (2011-12-01)

Resistance to Combined Anthracycline–Taxane Chemotherapy Is Associated with Altered Metabolism and Inflammation in Breast Carcinomas
by: Otília Menyhárt, et al.
Published: (2024-01-01)

Crystal Structure of the Cyclostreptin-Tubulin Adduct: Implications for Tubulin Activation by Taxane-Site Ligands
by: Francisco de Asís Balaguer, et al.
Published: (2019-03-01)

Desensitization in patients with hypersensitivity to platinum and taxane in gynecological cancers
by: Tibor A. Zwimpfer, et al.
Published: (2024-01-01)

Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis
by: Guo-Ying Liu, et al.
Published: (2018-05-01)